1. Home
  2. CTMX vs CHMI Comparison

CTMX vs CHMI Comparison

Compare CTMX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CHMI
  • Stock Information
  • Founded
  • CTMX 2008
  • CHMI 2012
  • Country
  • CTMX United States
  • CHMI United States
  • Employees
  • CTMX N/A
  • CHMI N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CHMI Real Estate Investment Trusts
  • Sector
  • CTMX Health Care
  • CHMI Real Estate
  • Exchange
  • CTMX Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • CTMX 349.6M
  • CHMI 105.3M
  • IPO Year
  • CTMX 2015
  • CHMI 2013
  • Fundamental
  • Price
  • CTMX $1.98
  • CHMI $2.63
  • Analyst Decision
  • CTMX Strong Buy
  • CHMI Hold
  • Analyst Count
  • CTMX 4
  • CHMI 1
  • Target Price
  • CTMX $5.13
  • CHMI N/A
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • CHMI 286.1K
  • Earning Date
  • CTMX 11-06-2025
  • CHMI 11-11-2025
  • Dividend Yield
  • CTMX N/A
  • CHMI 22.81%
  • EPS Growth
  • CTMX 263.20
  • CHMI N/A
  • EPS
  • CTMX 0.49
  • CHMI N/A
  • Revenue
  • CTMX $141,100,000.00
  • CHMI $25,461,000.00
  • Revenue This Year
  • CTMX N/A
  • CHMI N/A
  • Revenue Next Year
  • CTMX N/A
  • CHMI $54.92
  • P/E Ratio
  • CTMX $3.98
  • CHMI N/A
  • Revenue Growth
  • CTMX 18.01
  • CHMI 3.21
  • 52 Week Low
  • CTMX $0.40
  • CHMI $2.34
  • 52 Week High
  • CTMX $3.10
  • CHMI $3.81
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 43.81
  • CHMI 33.56
  • Support Level
  • CTMX $1.90
  • CHMI $2.56
  • Resistance Level
  • CTMX $2.03
  • CHMI $3.04
  • Average True Range (ATR)
  • CTMX 0.12
  • CHMI 0.08
  • MACD
  • CTMX -0.01
  • CHMI -0.04
  • Stochastic Oscillator
  • CTMX 17.50
  • CHMI 14.73

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: